ID: ALA5268678
Chembl Id: CHEMBL5268678
Max Phase: Preclinical
Molecular Formula: C17H14N4
Molecular Weight: 274.33
Associated Items:
Canonical SMILES: Cc1cc(C)cc(Nc2nc3ncccc3cc2C#N)c1
Standard InChI: InChI=1S/C17H14N4/c1-11-6-12(2)8-15(7-11)20-17-14(10-18)9-13-4-3-5-19-16(13)21-17/h3-9H,1-2H3,(H,19,20,21)
Standard InChI Key: NQFSEKXEJNUCJD-UHFFFAOYSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 274.33 | Molecular Weight (Monoisotopic): 274.1218 | AlogP: 3.86 | #Rotatable Bonds: 2 |
| Polar Surface Area: 61.60 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
| #RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
| CX Acidic pKa: ┄ | CX Basic pKa: 0.23 | CX LogP: 4.16 | CX LogD: 4.16 |
| Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.77 | Np Likeness Score: -1.56 |
| 1. Hou Z, Lockwood L, Zhang D, Occhiuto CJ, Mo L, Aldrich KE, Stoub HE, Gallo KA, Liby KT, Odom AL.. (2023) Exploring structural effects in a new class of NRF2 inhibitors., 14 (1.0): [PMID:36760735] [10.1039/d2md00211f] |
Source(1):
